Endoscopic Ultrasound-Guided, Percutaneous, and Transjugular Liver Biopsy: A Comparative Systematic Review and Meta-Analysis
| العنوان: | Endoscopic Ultrasound-Guided, Percutaneous, and Transjugular Liver Biopsy: A Comparative Systematic Review and Meta-Analysis |
|---|---|
| المؤلفون: | Marvin Ryou, Thiruvengadam Muniraj, Ahmad Najdat Bazarbashi, Basile Njei, Harry R. Aslanian, Thomas R. McCarty |
| المصدر: | Clinical Endoscopy, Vol 53, Iss 5, Pp 583-593 (2020) Clinical Endoscopy |
| بيانات النشر: | Hoon Jai Chun, 2020. |
| سنة النشر: | 2020 |
| مصطلحات موضوعية: | Endoscopic ultrasound, lcsh:Internal medicine, Percutaneous, Medicine (miscellaneous), Subgroup analysis, 03 medical and health sciences, 0302 clinical medicine, endoscopic ultrasound (eus), Biopsy, medicine, Transjugular liver biopsy, Radiology, Nuclear Medicine and imaging, lcsh:RC799-869, Adverse effect, lcsh:RC31-1245, liver biopsy, medicine.diagnostic_test, business.industry, Gastroenterology, interventional endoscopy, 030220 oncology & carcinogenesis, Meta-analysis, Liver biopsy, 030211 gastroenterology & hepatology, Original Article, lcsh:Diseases of the digestive system. Gastroenterology, Nuclear medicine, business |
| الوصف: | Background/Aims Percutaneous liver biopsy (PCLB) or transjugular liver biopsy (TJLB) have traditionally been performed to obtain a sample of hepatic tissue; however, endoscopic ultrasound-guided liver biopsy (EUSLB) has become an attractive alternative. The aim of this study was to compare the efficacy and safety of EUSLB, PCLB, and TJLB. Methods Search strategies were developed in accordance with PRISMA and MOOSE guidelines. Major outcomes included the following: adequacy of biopsy specimens (i.e., complete portal triads [CPT], total specimen length [TSL] in mm, and length of longest piece [LLP]) in mm), and rate of adverse events. Only studies comparing all biopsy approaches (i.e., EUSLB, PCLB, and TJLB) were included. Results Five studies (EUSLB [n=301]; PCLB [n=176]; and TJLB [n=179]) were included. Biopsy cumulative adequacy rates for EUSLB, PCLB, and TJLB were 93.51%, 98.27%, and 97.61%, respectively. Based on the subgroup analysis limited to EUS biopsy needles in current clinical practice, there was no difference in biopsy adequacy or adverse events for EUSLB compared to PCLB and TJLB (all p>0.050). A comparison of EUSLB and PCLB revealed no difference between specimens regarding both CPT (p=0.079) and LLP (p=0.085); however, a longer TSL (p |
| اللغة: | English |
| تدمد: | 2234-2443 2234-2400 |
| الوصول الحر: | https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b90c610ee285306bdb962639b2541365Test http://www.e-ce.org/upload/pdf/ce-2019-211.pdfTest |
| حقوق: | OPEN |
| رقم الانضمام: | edsair.doi.dedup.....b90c610ee285306bdb962639b2541365 |
| قاعدة البيانات: | OpenAIRE |
| تدمد: | 22342443 22342400 |
|---|